CRY Share Price

Open 18.25 Change Price %
High 18.55 1 Day 0.00 0.00
Low 18.25 1 Week -0.65 -3.44
Close 18.25 1 Month 2.60 16.61
Volume 136750 1 Year 6.80 59.39
52 Week High 20.15
52 Week Low 11.35
CRY Important Levels
Resistance 2 18.53
Resistance 1 18.41
Pivot 18.35
Support 1 18.09
Support 2 17.97
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
BAC 23.05 1.36%
BAC 23.05 1.36%
BAC 23.05 1.36%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
DYN 9.12 25.62%
CGI 2.30 17.95%
SOL 2.89 14.68%
SOL 2.89 14.68%
SOL 2.89 14.68%
SOL 2.89 14.68%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

CryoLife, Inc. (NYSE: CRY)

CRY Technical Analysis 4
As on 19th May 2017 CRY Share Price closed @ 18.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 16.78 & Strong Buy for SHORT-TERM with Stoploss of 16.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
CRY Target for May
1st Target up-side 21.05
2nd Target up-side 23.09
3rd Target up-side 25.13
1st Target down-side 15.25
2nd Target down-side 13.21
3rd Target down-side 11.17
CRY Other Details
Segment EQ
Market Capital 172325952.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cryolife.com
CRY Address
CRY
1655 Roberts Boulevard N.W.
Kennesaw, GA 30144
United States
Phone: 770-419-3355
Fax: 770-426-0031
CRY Latest News
Interactive Technical Analysis Chart CryoLife, Inc. ( CRY NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CryoLife, Inc.
CRY Business Profile
CryoLife, Inc., together with its subsidiaries, develops, manufactures, and commercializes medical devices for cardiac and vascular applications; and preserves and distributes human tissues for transplantation worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers surgical sealants and hemostats, including BioGlue Surgical Adhesive, a polymeric surgical adhesive based on bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; and PerClot, an absorbable powdered hemostat agent for use in surgical procedures. The company also provides Revascularization technologies, including Transmyocardial Revascularization system for treating patients with stable angina that is not responsive to conventional therapy; and markets HeRO Graft, a graft-based solution for end-stage renal disease hemodialysis patients with limited access options. In addition, it distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using the proprietary SynerGraft technology; and vascular tissues, such as CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company markets its products to physicians through field representatives, cardiac specialists, and independent distributors; and preservation services to organ and tissue procurement organizations, implanting physicians, and prospective tissue recipients. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.